{
     "PMID": "23295393",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20130828",
     "LR": "20131121",
     "IS": "1872-7549 (Electronic) 0166-4328 (Linking)",
     "VI": "243",
     "DP": "2013 Apr 15",
     "TI": "Peripheral administration of D-cycloserine rescues memory consolidation following bacterial endotoxin exposure.",
     "PG": "38-43",
     "LID": "10.1016/j.bbr.2012.12.053 [doi] S0166-4328(12)00843-1 [pii]",
     "AB": "In the current study, the partial NMDA receptor agonist D-cycloserine (DCS) rescued memory consolidation following systemic bacterial endotoxin exposure. DCS failed, however, to restore hippocampal BDNF mRNA levels that were diminished following a systemic administration of LPS, and did not alter NR1 or NR2C NMDA receptor subunit expression. These results extend prior research into the role of DCS in neural-immune interactions, and indicate that the detrimental effects of peripheral LPS administration on consolidation of contextual fear memory may be ameliorated with DCS treatment, though the mechanisms underlying these effects are currently unclear.",
     "CI": [
          "Copyright (c) 2013 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Kranjac, Dinko",
          "Koster, Kyle M",
          "Kahn, Marielle S",
          "Eimerbrink, Micah J",
          "Womble, Brent M",
          "Cooper, Brenton G",
          "Chumley, Michael J",
          "Boehm, Gary W"
     ],
     "AU": [
          "Kranjac D",
          "Koster KM",
          "Kahn MS",
          "Eimerbrink MJ",
          "Womble BM",
          "Cooper BG",
          "Chumley MJ",
          "Boehm GW"
     ],
     "AD": "Department of Psychology, Texas Christian University, Fort Worth, TX 76129, USA.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20130104",
     "PL": "Netherlands",
     "TA": "Behav Brain Res",
     "JT": "Behavioural brain research",
     "JID": "8004872",
     "RN": [
          "0 (Antimetabolites)",
          "0 (Lipopolysaccharides)",
          "0 (NR1 NMDA receptor)",
          "0 (NR2C NMDA receptor)",
          "0 (RNA, Messenger)",
          "0 (Receptors, N-Methyl-D-Aspartate)",
          "95IK5KI84Z (Cycloserine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antimetabolites/pharmacology/therapeutic use",
          "Behavior, Animal/drug effects",
          "Cycloserine/pharmacology/*therapeutic use",
          "*Escherichia coli/drug effects",
          "Fear/drug effects",
          "Hippocampus/*drug effects/metabolism/microbiology",
          "Lipopolysaccharides/administration & dosage/*pharmacology",
          "Male",
          "Memory/*drug effects",
          "Mice",
          "Mice, Inbred C57BL",
          "Neuropsychological Tests",
          "RNA, Messenger/drug effects",
          "Receptors, N-Methyl-D-Aspartate/biosynthesis"
     ],
     "EDAT": "2013/01/09 06:00",
     "MHDA": "2013/08/29 06:00",
     "CRDT": [
          "2013/01/09 06:00"
     ],
     "PHST": [
          "2012/10/01 00:00 [received]",
          "2012/12/21 00:00 [revised]",
          "2012/12/27 00:00 [accepted]",
          "2013/01/09 06:00 [entrez]",
          "2013/01/09 06:00 [pubmed]",
          "2013/08/29 06:00 [medline]"
     ],
     "AID": [
          "S0166-4328(12)00843-1 [pii]",
          "10.1016/j.bbr.2012.12.053 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Behav Brain Res. 2013 Apr 15;243:38-43. doi: 10.1016/j.bbr.2012.12.053. Epub 2013 Jan 4.",
     "term": "hippocampus"
}